Citius Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Citius Pharmaceuticals, Inc.‘s stocks are currently a part of 36 hedge funds’ portfolios, which represents 3% of the total amount of its stocks outstanding. This makes up a total of 4.38M shares of Citius Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -69.24% or -9.86M shares fewer. As for the holding position changes, 13.89% (5) of current hedge fund investors increased the number of shares held, 25% (9) of current holders sold a part of the shares held, and 11.11% (4) closed the holdings completely. 7 hedge funds are new holders of Citius Pharmaceuticals, Inc. stock in Q1 2023, it is 19.44% of total holders.
Hedge funds holding Citius Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 6 |
|---|---|
| Q3 2018 | 9 |
| Q4 2018 | 8 |
| Q1 2019 | 11 |
| Q2 2019 | 10 |
| Q3 2019 | 11 |
| Q4 2019 | 9 |
| Q1 2020 | 10 |
| Q2 2020 | 13 |
| Q3 2020 | 16 |
| Q4 2020 | 22 |
| Q1 2021 | 37 |
| Q2 2021 | 71 |
| Q3 2021 | 68 |
| Q4 2021 | 71 |
| Q1 2022 | 67 |
| Q2 2022 | 51 |
| Q3 2022 | 48 |
| Q4 2022 | 50 |
| Q1 2023 | 36 |
Hedge funds changes in Citius Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 1 | 1 | 2 | 1 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 4 | 1 | 1 | 1 | 2 |
| Q4 2018 | 1 | 4 | 0 | 2 | 1 |
| Q1 2019 | 6 | 1 | 2 | 3 | -1 |
| Q2 2019 | 2 | 1 | 1 | 3 | 3 |
| Q3 2019 | 4 | 3 | 0 | 3 | 1 |
| Q4 2019 | 3 | 1 | 1 | 6 | -2 |
| Q1 2020 | 5 | 1 | 1 | 3 | 0 |
| Q2 2020 | 7 | 3 | 1 | 4 | -2 |
| Q3 2020 | 8 | 4 | 1 | 4 | -1 |
| Q4 2020 | 11 | 5 | 0 | 5 | 1 |
| Q1 2021 | 20 | 11 | 1 | 5 | 0 |
| Q2 2021 | 43 | 17 | 5 | 9 | -3 |
| Q3 2021 | 14 | 26 | 17 | 17 | -6 |
| Q4 2021 | 13 | 22 | 23 | 8 | 5 |
| Q1 2022 | 6 | 20 | 24 | 11 | 6 |
| Q2 2022 | 13 | 10 | 16 | 27 | -15 |
| Q3 2022 | 12 | 6 | 12 | 15 | 3 |
| Q4 2022 | 11 | 16 | 7 | 8 | 8 |
| Q1 2023 | 7 | 5 | 9 | 4 | 11 |
Hedge funds changes in Citius Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 295,000 | 116,000 |
| Q3 2021 | 1,410,000 | 553,000 |
| Q4 2021 | 801,000 | 319,000 |
| Q1 2022 | 1,048,000 | 135,000 |
| Q2 2022 | 468,000 | 73,000 |
| Q3 2022 | 1,429,000 | 108,000 |
| Q4 2022 | 774,232 | 73,211 |
| Q1 2023 | 160,839,000 | 5,193,000 |